Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture
May 13, 2021 16:02 ET | Kinnate Biopharma
Financing led by OrbiMed Asia Partners, with participation from OrbiMed Private Investments and Foresite CapitalThe joint venture will have exclusive license to develop and commercialize Kinnate’s...
Global $12.7 Billion Pharmacogenomics Markets to 2026 with Profiles of Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Novartis, Oxford Nanopore Technologies and Thermo Fisher Scientific
May 11, 2021 08:13 ET | Research and Markets
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market 2021-2026" report has been added to's offering. The global market for pharmacogenomics should...
Scipher Applies Spectra™ Platform to Discover Drugs Targeting Autoimmune Patients Refractory to Existing Therapies
May 04, 2021 08:00 ET | Scipher Medicine Corporation
- Leverages large genomic database from Scipher’s testing business.- Proven Spectra™ platform brings precision therapeutics to autoimmune diseases.- Program commercialized through pharma partnerships....
The Worldwide Patient-Derived Xenograft/PDX Model Industry is Expected to Reach $299 Million by 2026
April 30, 2021 06:33 ET | Research and Markets
Dublin, April 30, 2021 (GLOBE NEWSWIRE) -- The "Patient-Derived Xenograft/PDX Model Market by Type (Mouse, Rat), Tumor Type (Gastrointestinal, Gynecological, Hematological), Application (Preclinical...
2021 Global Exosome Market Size, Forecast, Trials and Trends, Featuring Profiles of 107 Competitors Including Abbexa, Ltd., Abnova, Aruna Bio and Tavec Pharma
April 22, 2021 06:13 ET | Research and Markets
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "The Global Exosome Market - Market Size, Forecast, Trials, and Trends, 2021" report has been added to's offering. ...
Global Clinical Genomics Markets Report 2021: Mergers, Acquisitions, and Partnerships Accelerate Adoption of Clinical Genomics
April 14, 2021 04:13 ET | Research and Markets
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics" report has been added to's...
ImpriMed Raises $8M to Commercialize AI-Driven Personalized Drug Response Prediction Service in Pet Cancer Market
April 13, 2021 08:00 ET | ImpriMed, Inc.
PALO ALTO, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- ImpriMed, Inc., a leading veterinary precision medicine startup has recently closed a total of $8 million in Pre-Series A funding with $7.7...
Abcam and MEDx extend precision medicine strategic partnership
April 12, 2021 05:00 ET | Abcam
Building on existing three-year collaborationFocusing on co-development of companion and in vitro diagnostic kits to support demand in China CAMBRIDGE, United Kingdom and SHANGHAI, China, April 12,...
Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
April 06, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, April 06, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...
Allarity Therapeutics Submits Premarket Approval Application to U.S. FDA for DRP® Companion Diagnostic for Dovitinib
April 02, 2021 07:00 ET | Allarity Therapeutics A/S
- Submission precedes expected NDA filing for dovitinib in 2021 - Premarket Approval will allow U.S. marketing of DRP-Dovitinib as companion diagnostic to dovitinib Press release ...